| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Advances in clinical immunotherapy for gastric cancer
|
Li, Kexin
|
|
|
1876 |
2 |
p.
|
artikel
|
| 2 |
A holistic view on c-Kit in cancer: Structure, signaling, pathophysiology and its inhibitors
|
Pathania, Shelly
|
|
|
1876 |
2 |
p.
|
artikel
|
| 3 |
Clinical considerations of CDK4/6 inhibitors in triple-negative breast cancer
|
Wang, Runtian
|
|
|
1876 |
2 |
p.
|
artikel
|
| 4 |
Clinicopathologic features and treatment advances in cancers with HER2 alterations
|
Cen, Shuyi
|
|
|
1876 |
2 |
p.
|
artikel
|
| 5 |
Combinatorial therapy in tumor microenvironment: Where do we stand?
|
Kumari, Smita
|
|
|
1876 |
2 |
p.
|
artikel
|
| 6 |
Contribution of CXCR3-mediated signaling in the metastatic cascade of solid malignancies
|
Cannon, Andrew
|
|
|
1876 |
2 |
p.
|
artikel
|
| 7 |
Drug resistance in colorectal cancer: An epigenetic overview
|
Luo, Maochao
|
|
|
1876 |
2 |
p.
|
artikel
|
| 8 |
Editorial Board
|
|
|
|
1876 |
2 |
p.
|
artikel
|
| 9 |
Elucidating the mechanisms of Temozolomide resistance in gliomas and the strategies to overcome the resistance.
|
Tomar, Manendra Singh
|
|
|
1876 |
2 |
p.
|
artikel
|
| 10 |
Emerging roles of the nectin family of cell adhesion molecules in tumour-associated pathways
|
Duraivelan, Kheerthana
|
|
|
1876 |
2 |
p.
|
artikel
|
| 11 |
FGFR signaling and endocrine resistance in breast cancer: Challenges for the clinical development of FGFR inhibitors
|
Servetto, Alberto
|
|
|
1876 |
2 |
p.
|
artikel
|
| 12 |
Gastroenteropancreatic neuroendocrine neoplasms G3: Novel insights and unmet needs
|
Shi, Ming
|
|
|
1876 |
2 |
p.
|
artikel
|
| 13 |
βIII-tubulin overexpression in cancer: Causes, consequences, and potential therapies
|
Kanakkanthara, Arun
|
|
|
1876 |
2 |
p.
|
artikel
|
| 14 |
Implications of viral infection in cancer development
|
Kellogg, Caroline
|
|
|
1876 |
2 |
p.
|
artikel
|
| 15 |
Inhibiting homologous recombination by targeting RAD51 protein
|
Demeyer, A.
|
|
|
1876 |
2 |
p.
|
artikel
|
| 16 |
Intestinal multicellular organoids to study colorectal cancer
|
Idris, Musa
|
|
|
1876 |
2 |
p.
|
artikel
|
| 17 |
Ion channels as key partners of cytoskeleton in cancer disease
|
Rodat-Despoix, Lise
|
|
|
1876 |
2 |
p.
|
artikel
|
| 18 |
Is tumour-expressed aminopeptidase N (APN/CD13) structurally and functionally unique?
|
Barnieh, Francis M.
|
|
|
1876 |
2 |
p.
|
artikel
|
| 19 |
Keep your eyes peeled for long noncoding RNAs: Explaining their boundless role in cancer metastasis, drug resistance, and clinical application
|
Barik, Ganesh Kumar
|
|
|
1876 |
2 |
p.
|
artikel
|
| 20 |
Machine Learning in Epigenomics: Insights into Cancer Biology and Medicine
|
Arslan, Emre
|
|
|
1876 |
2 |
p.
|
artikel
|
| 21 |
miRNAs and androgen deprivation therapy for prostate cancer
|
Konoshenko, Maria Yu
|
|
|
1876 |
2 |
p.
|
artikel
|
| 22 |
Multifaceted roles of HSF1 in cell death: A state-of-the-art review
|
Zhang, Bingwei
|
|
|
1876 |
2 |
p.
|
artikel
|
| 23 |
New insights into exosome mediated tumor-immune escape: Clinical perspectives and therapeutic strategies
|
Pathania, Anup S.
|
|
|
1876 |
2 |
p.
|
artikel
|
| 24 |
Non-coding RNA-mediated autophagy in cancer: A protumor or antitumor factor?
|
Liang, Jianqiang
|
|
|
1876 |
2 |
p.
|
artikel
|
| 25 |
Non-small cell lung cancer: Emerging molecular targeted and immunotherapeutic agents
|
Singh, Takshveer
|
|
|
1876 |
2 |
p.
|
artikel
|
| 26 |
PARP inhibitor resistance in ovarian cancer: Underlying mechanisms and therapeutic approaches targeting the ATR/CHK1 pathway
|
Biegała, Łukasz
|
|
|
1876 |
2 |
p.
|
artikel
|
| 27 |
PDLIM2: Signaling pathways and functions in cancer suppression and host immunity
|
Guo, Zong Sheng
|
|
|
1876 |
2 |
p.
|
artikel
|
| 28 |
Pericytes cross-talks within the tumor microenvironment
|
Picoli, Caroline C.
|
|
|
1876 |
2 |
p.
|
artikel
|
| 29 |
Precision medicine and phosphoproteomics for the identification of novel targeted therapeutic avenues in sarcomas
|
Fordham, Ashleigh M.
|
|
|
1876 |
2 |
p.
|
artikel
|
| 30 |
Preface
|
Curtis, Christina
|
|
|
1876 |
2 |
p.
|
artikel
|
| 31 |
Prognostic features of the tumour microenvironment in oesophageal adenocarcinoma
|
McShane, Rhiannon
|
|
|
1876 |
2 |
p.
|
artikel
|
| 32 |
Progress and challenges of immunotherapy in triple-negative breast cancer
|
Zhu, Yinxing
|
|
|
1876 |
2 |
p.
|
artikel
|
| 33 |
Protein domain-based approaches for the identification and prioritization of therapeutically actionable cancer variants
|
Grillo, Elisabetta
|
|
|
1876 |
2 |
p.
|
artikel
|
| 34 |
Recent advances in understanding the molecular role of phosphoinositide-specific phospholipase C gamma 1 as an emerging onco-driver and novel therapeutic target in human carcinogenesis
|
Mandal, Supratim
|
|
|
1876 |
2 |
p.
|
artikel
|
| 35 |
Regulatory role of Non-canonical DNA Polymorphisms in human genome and their relevance in Cancer
|
Pandya, Nirali
|
|
|
1876 |
2 |
p.
|
artikel
|
| 36 |
Significance of intratumoral infiltration of B cells in cancer immunotherapy: From a single cell perspective
|
Gu, Sijia
|
|
|
1876 |
2 |
p.
|
artikel
|
| 37 |
Soluble CD95L in cancers and chronic inflammatory disorders, a new therapeutic target?
|
Kurma, Keerthi
|
|
|
1876 |
2 |
p.
|
artikel
|
| 38 |
Targeted and immuno-based therapies in sarcoma: mechanisms and advances in clinical trials
|
Tang, Fan
|
|
|
1876 |
2 |
p.
|
artikel
|
| 39 |
Targeting ion channels for the treatment of lung cancer
|
Zhang, Liqin
|
|
|
1876 |
2 |
p.
|
artikel
|
| 40 |
The application of CA72-4 in the diagnosis, prognosis, and treatment of gastric cancer
|
Xu, Yitian
|
|
|
1876 |
2 |
p.
|
artikel
|
| 41 |
The implication of IL-6 in the invasiveness and chemoresistance of ovarian cancer cells. Systematic review of its potential role as a biomarker in ovarian cancer patients
|
Szulc-Kielbik, Izabela
|
|
|
1876 |
2 |
p.
|
artikel
|
| 42 |
The intratumoural microbiota in cancer: new insights from inside
|
An, Yaping
|
|
|
1876 |
2 |
p.
|
artikel
|
| 43 |
The multifaceted roles of gasdermins in cancer biology and oncologic therapies
|
Sarrió, David
|
|
|
1876 |
2 |
p.
|
artikel
|
| 44 |
The progress of immune checkpoint therapy in primary liver cancer
|
Zheng, Yimin
|
|
|
1876 |
2 |
p.
|
artikel
|
| 45 |
The RNA m6A writer METTL14 in cancers: Roles, structures, and applications
|
Zhou, Huimin
|
|
|
1876 |
2 |
p.
|
artikel
|
| 46 |
The role of autophagy in pancreatic cancer progression
|
Wang, Yuanyang
|
|
|
1876 |
2 |
p.
|
artikel
|
| 47 |
The role of 5-HT metabolism in cancer
|
Ye, Di
|
|
|
1876 |
2 |
p.
|
artikel
|
| 48 |
The transcriptional stress response and its implications in cancer treatment
|
Cruz-Ruiz, Samantha
|
|
|
1876 |
2 |
p.
|
artikel
|
| 49 |
The use of nanotechnology to combat liver cancer: Progress and perspectives
|
Mintz, Keenan J.
|
|
|
1876 |
2 |
p.
|
artikel
|
| 50 |
Translational challenges in pancreatic neuroendocrine tumor immunotherapy
|
Egal, Erika Said Abu
|
|
|
1876 |
2 |
p.
|
artikel
|
Tijdschrift beschrijving